Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...
Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...
Sepsis is an underestimated killer. Nearly a quarter of patients treated for sepsis in hospital will die, but because so many different illnesses can ...